Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

Log in / Sign up

← Back to home

Shenzhen Mingsight Relin Pharmaceuticals Co., Ltd.

Clinical trials sponsored by Shenzhen Mingsight Relin Pharmaceuticals Co., Ltd., explained in plain language.

Upcoming readouts

Trials from this sponsor expected to report results within the next 12 months.

New pill could replace eye injections for Diabetes-Related vision loss Results expected Oct 2026 (estimated)

Browse trials soon ready across all sponsors →

Trials to join now! 1

New pill could replace eye injections for Diabetes-Related vision loss

Disease control Recruiting now

This early-stage trial tests an oral drug called MS-553 in 45 people with diabetic macular edema, a condition that causes vision loss in people with diabetes. Participants take the drug daily for 8 weeks. The main goal is to check safety, but researchers will also measure changes…

Phase 1 • Sponsor: Shenzhen MingSight Relin Pharmaceuticals Co., Ltd. • Aim: Disease control

Last updated Jun 27, 2026 07:52 UTC